Genetic Mapping Predicts Risk of Cardiovascular Events in People With Type 2 Diabetes
Researchers report findings from the ACCORD trial that evaluated the relationship of a blood pressure polygenic risk score with cardiovascular outcomes in individuals with type 2 diabetes.